Sarcopenia Can Be Physiological or Pathological, Primary or Secondary
DOI:
https://doi.org/10.15605/jafes.041.03.5127Keywords:
sarcopenia, muscle wasting, cardiovascular disease, agingAbstract
In response to the article, “Interrelationship of Sarcopenia and Cardiovascular Diseases:
A Review of Potential Mechanisms and Management,” by Rivera, et al., published in JAFES Vol. 39 No. 1.
We read with interest the review article by Rivera et al., on the relationship between sarcopenia and cardiovascular diseases such as atherosclerosis, hypertension, coronary heart disease, and heart failure.1 Cardiovascular diseases have been found to trigger sarcopenia through processes such as inflammation, oxidative stress, endothelial dysfunction, neuronal and hormonal changes, malnutrition, and reduced physical activity.1 It was concluded that cardiovascular drugs, hormone replacement, changes in diet and nutritional intake, and physical activity can attenuate sarcopenia.1 The study is noteworthy, but some points warrant discussion.
Downloads
References
1. Rivera FB, Escolano BT, Nifas FM, et al. Interrelationship of sarcopenia and cardiovascular diseases: A review of potential mechanisms and management. J ASEAN Fed Endocr Soc. 2024;39(1):69-78. https://pubmed.ncbi.nlm.nih.gov/38863922 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11163321 https://doi.org/10.15605/jafes.039.01.03
2. Powers SK, Lynch GS, Murphy KT, Reid MB, Zijdewind I. Disease-induced skeletal muscle atrophy and fatigue. Med Sci Sports Exerc. 2016;48(11):2307-19. https://pubmed.ncbi.nlm.nih.gov/27128663 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069191 https://doi.org/10.1249/MSS.0000000000000975
3. Kemmler W, Bebenek M, Engelke K, von Stengel S. Impact of whole-body electromyostimulation on body composition in elderly women at risk for sarcopenia: The training and electrostimulation trial (TEST-III). Age (Dordr). 2014;36(1):395-406. https://pubmed.ncbi.nlm.nih.gov/23949160 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889893 https://doi.org/10.1007/s11357-013-9575-2
4. Campins L, Camps M, Riera A, Pleguezuelos E, Yebenes JC, Serra-Prat M. Oral drugs related with muscle wasting and sarcopenia. A review. Pharmacology. 2017;99(1-2):1-8. https://pubmed.ncbi.nlm.nih.gov/27578190 https://doi.org/10.1159/000448247
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Josef Finsterer
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The full license text is available at: http://creativecommons.org/licenses/by-nc/3.0/legalcode.
To request permission to translate, reproduce, download, or use articles or images for commercial reuse or business purposes from the Journal of the ASEAN Federation of Endocrine Societies (JAFES), kindly complete the Permission Request for Use of Copyrighted Material Form and email jafes@asia.com or jafes.editor@gmail.com.
A written agreement will be issued to the requester once permission has been granted.
